Generic drug utilization in the Medicare Part D program.
| Corporate Author: | United States. Department of Health and Human Services. Office of Inspector General (Author) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
[Washington, D.C.] :
Department of Health and Human Services, Office of Inspector General,
2007.
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo69109 |
Similar Items
Generic drug utilization in state Medicaid programs.
Published: (2006)
Published: (2006)
Medicare payments for newly available generic drugs.
Published: (2011)
Published: (2011)
The impact of high-priced generic drugs on Medicare and Medicaid.
Published: (1998)
Published: (1998)
Monitoring Medicare Part B drug prices : a comparison of average sales prices to average manufacturer prices.
Published: (2006)
Published: (2006)
Risk evaluation and mitigation strategies (REMS) and generic drugs /
by: Dabrowska, Agata
Published: (2018)
by: Dabrowska, Agata
Published: (2018)
Perspectives of drug manufacturers : abbreviated new drug applications.
Published: (1990)
Published: (1990)
Fin de la interrupción de la cobertura.
Published: (2018)
Published: (2018)
Inappropriate Medicare Part D payments for Schedule II drugs billed as refills.
Published: (2012)
Published: (2012)
Calculation of volume-weighted average sales price for Medicare Part B prescription drugs.
Published: (2006)
Published: (2006)
Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling.
Published: (2014)
Published: (2014)
Comparing pharmacy reimbursement : Medicare Part D to Medicaid.
Published: (2009)
Published: (2009)
Medicare payment for irinotecan.
Published: (2008)
Published: (2008)
Medicare prescription drug coverage : how to join a Medicare drug plan.
Published: (2010)
Published: (2010)
Audits of Medicare prescription drug plan sponsors.
Published: (2011)
Published: (2011)
Centers for Medicare & Medicaid Services audits of Medicare Part D bids.
Published: (2008)
Published: (2008)
Medicaid drug price comparisons : average manufacturer price to published prices.
Published: (2005)
Published: (2005)
Centers for Medicare & Medicaid Services audits of Medicare Part D bids.
Published: (2008)
Published: (2008)
Enrolling in Medicare Part A & Part B /
Published: (2016)
Published: (2016)
Medicaid drug price comparisons : average sales price to average wholesale price.
Published: (2005)
Published: (2005)
Medicare reimbursement for lupron.
Published: (2004)
Published: (2004)
Providers opting out of Medicare prior to program exclusion.
Published: (2000)
Published: (2000)
Medicare financial status : in brief /
by: Davis, Patricia A. (Specialist in Health Care Financing)
Published: (2018)
by: Davis, Patricia A. (Specialist in Health Care Financing)
Published: (2018)
Medicare drug integrity contractors' identification of potential Part D fraud and abuse.
Published: (2009)
Published: (2009)
Examining the Proposed Medicare Part B Drug Demonstration.
Published: (2016)
Published: (2016)
Beneficiary utilization of albuterol and levalbuterol under Medicare Part B.
Published: (2009)
Published: (2009)
Why Are Some Generic Drugs Skyrocketing in Price?
Published: (2014)
Published: (2014)
Retail pharmacy participation in Medicare Part D prescription drug plans in 2006.
Published: (2007)
Published: (2007)
Medicare reimbursement for new end stage renal disease drugs.
Published: (2006)
Published: (2006)
Medicare drug plan sponsors' identification of potential fraud and abuse.
Published: (2008)
Published: (2008)
Medicare made easy /
by: Inlander, Charles B.
Published: (1999)
by: Inlander, Charles B.
Published: (1999)
How Medicare prescription drug coverage works with a Medicare Advantage Plan or Medicare Cost Plan.
Published: (2018)
Published: (2018)
Deficit Reduction Act of 2005 : impact on the Medicaid federal upper limit program.
Published: (2007)
Published: (2007)
Experiences of health maintenance organizations with pharmacy benefit management companies.
Published: (1997)
Published: (1997)
Proposed FDA user fee acts : Generic Drug User Fee Amendments of 2012 (GDUFA) and Biosimilar User Fee Act of 2012 (BSUFA) /
by: Thaul, Susan, et al.
Published: (2019)
by: Thaul, Susan, et al.
Published: (2019)
Midyear formulary changes in Medicare prescription drug plans.
Published: (2009)
Published: (2009)
Memorandum report : payment for drugs under the hospital outpatient prospective payment system.
Published: (2010)
Published: (2010)
Enrolling in Medicare Part A & Part B /
The Medicare drug benefit : are private insurers getting good discounts for the taxpayer? : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2010)
Published: (2010)
Creating a Medicare prescription drug benefit : assessing efforts to help America's low-income seniors : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, April 17, 2002.
Published: (2002)
Published: (2002)
1999 Medicare and Medicaid benefits.
Published: (1999)
Published: (1999)